Our Reach — 35+ Markets,
6 Continents, One Source.
Explore Laborate's pharmaceutical export footprint across Asia Pacific, Middle East, Africa, Latin America, CIS, and Europe — all shipped from WHO-GMP certified manufacturing facilities in North India.
Laborate's Global Export Footprint
Hover over a region pin to explore active markets, product categories, and partnership models. All regions served from WHO-GMP certified facilities in India.
Active export markets as of 2026. Regulatory dossiers filed in 60+ countries. Hover region pins for market detail. View complete country list →
Explore by Region
Expand any region to see active markets, the primary business model, and regulatory certification requirements for that geography.
Asia Pacific
Asia Pacific
Active Markets
Business Model
Primarily through established distribution partners and government institution supply. Key markets operate via long-term exclusive distribution agreements with local pharmaceutical importers.
Certifications
WHO-GMP certification accepted across all Asia Pacific markets. PIC/S-aligned QMS for regulated markets (Malaysia, Philippines). Country-specific dossier requirements apply.
Middle East & North Africa
Middle East & North Africa
Active Markets
Business Model
Branded generics and OTC products through established import agents. GCC markets require local Ministry of Health registration and approved importer partnerships.
Certifications
WHO-GMP plus country-specific MOH approvals. Saudi SFDA, UAE MOH, and Kuwait NHRA registrations maintained for key product lines. Certificate of Free Sale provided for all shipments.
Africa
Africa
Active Markets
Business Model
East Africa via regional distributors; West Africa through institution-level supply chains. Anti-malarials, anti-infectives, and essential medicines are the primary product categories.
Certifications
WHO-GMP is the primary qualification for most African markets. East Africa requires KEBS/TFDA/FMHACA national registration. South Africa requires SAHPRA (MCC) approval for full market access.
Latin America & Caribbean
Latin America & Caribbean
Active Markets
Business Model
Local pharma distributors with national import licences. Respiratory, gastrointestinal, and anti-infective generics are primary products. Dossiers maintained with INVIMA and Andean health authorities.
Certifications
WHO-GMP required for all Andean Community markets. Colombian INVIMA, Ecuadorian ARCSA, and Peruvian DIGEMID registrations required. Brand dossiers and Certificates of Free Sale maintained.
CIS & Central Asia
CIS & Central Asia
Active Markets
Business Model
Long-term exclusive distributor relationships in Kazakh and Uzbek markets. Branded generic products with Cyrillic labelling available. Dossiers registered with national pharmaceutical agencies.
Certifications
WHO-GMP accepted across CIS markets. Kazakhstan RK and Uzbekistan AGTV agency registrations maintained. Full dossier documentation in Russian and Cyrillic available on request.
Europe
Europe
Active Markets
Business Model
Early-stage regulated-market entry through authorised EU representatives. Generics and speciality pharma via contract supply agreements. EU-GMP compliance roadmap active.
Certifications
EU-GMP documentation alignment in progress. PIC/S-compliant QMS in place. EDQM Certificate of Suitability (CEP) applications under preparation for key API categories.
Regulatory dossiers filed in 60+ countries, including markets not yet active. Contact our International Business team to enquire about distribution opportunities in your market. View complete country list →
North India — The Source of Every Shipment
All Laborate products exported worldwide originate from our WHO-GMP certified manufacturing campus spanning three strategic locations in northern India — Panipat and Karnal in Haryana, and Paonta Sahib on the Himachal Pradesh border.
Panipat, Haryana
Head office & primary export manufacturing campus. Solid dosage forms, liquids, and injectables. WHO-GMP certified, ISO 9001:2015.
Karnal, Haryana
Secondary manufacturing and packaging site. Speciality tablets, capsules, and nutraceuticals. WHO-GMP certified, dedicated OSD block.
Paonta Sahib, Himachal Pradesh
Excise-exempt Himachal facility. Ophthalmics, injectables, and regulated-market product lines. WHO-GMP, PIC/S-aligned QMS.
Built for Global Supply
From documentation to cold chain, our export infrastructure is designed for reliable international pharmaceutical supply — compliant, traceable, and on time.
Export Documentation
Full suite of export documents — Certificate of Analysis, Certificate of Origin, Certificate of Free Sale, WHO-GMP certificates, and country-specific import authorisations prepared in-house.
Regulatory Dossiers
Regulatory dossiers in CTD, WHO, and ACTD formats — covering CMC, preclinical, and clinical sections — with in-house regulatory affairs support for new market submissions.
International Logistics
Multi-modal freight — air and sea — with DDP, DAP, and FOB Incoterms. Dedicated freight forwarder partnerships across 35+ markets. 98.2% on-time dispatch rate maintained.
Serialisation & Track-Trace
GS1-compliant 2D barcode serialisation, tamper-evident packaging, and aggregation reports for EU Falsified Medicines Directive, DSCSA, and national track-trace requirements.
Cold Chain Management
Temperature-controlled storage and transit for 2–8°C and controlled-room-temperature products. GDP-compliant shipping with real-time data loggers and carrier qualification records.
Dedicated Key Account Support
Each international partner is assigned a named Key Account Manager — one point of contact for orders, documentation, regulatory queries, and post-shipment support.
Quality Recognised Globally
Our certifications and regulatory registrations reflect Laborate's commitment to meeting the highest international pharmaceutical quality standards across every export market.
WHO-GMP Certification
All five manufacturing facilities hold current WHO-GMP certificates — the gold standard for pharmaceutical export. Accepted across 100+ countries including Asia Pacific, MENA, Africa, and Latin America.
ISO 9001:2015
ISO 9001:2015 certified quality management system across all facilities — ensuring consistent process control, corrective action management, and continual improvement in manufacturing quality.
PIC/S Compliance
Quality systems aligned with PIC/S guidelines — enabling smoother regulatory review for market applications in Malaysia, Philippines, GCC, and other PIC/S-referencing regulatory frameworks.
USFDA Readiness
Facilities and QMS prepared for USFDA pre-approval inspections. ANDA dossier support services available for US market-entry partners. Full electronic submission format available on request.
EU-GMP Documentation
EU-GMP Site Master File maintained for all facilities. EDQM Certificate of Suitability (CEP) applications in progress for key API categories. EU authorised representative model available.
Country Registrations
Over 400 active product registrations across 35+ countries — maintained with renewal tracking, post-approval change management, and dossier updates handled in-house by our regulatory affairs team.
International Business
Interested in a Distribution Partnership?
Our International Business Development team works with distributors, healthcare institutions, and brands across 35+ markets. Get in touch to discuss product range, regulatory requirements, and partnership terms.
Speak with Our International Business Team
Enquiries handled by regional export specialists — not a contact form. We respond within one business day.